Lau Loretta, Mick Paul, Nunez Desmond A
Western Sussex Hospitals NHS Foundation Trust, Worthing, UK.
Cochrane Database Syst Rev. 2018 Apr 6;4(4):CD004741. doi: 10.1002/14651858.CD004741.pub3.
This is an update of a Cochrane review first published in The Cochrane Library in Issue 4, 2008 and previously updated in 2011.Acute suppurative otitis media is one of the most common infectious diseases in childhood. Recurrent acute otitis media is defined for the purposes of this review as either three or more acute infections of the middle ear cleft in a six-month period, or at least four episodes in a year. Strategies for managing the condition include the assessment and modification of risk factors where possible, repeated courses of antibiotics for each new infection, antibiotic prophylaxis and the insertion of ventilation tubes (grommets).
To establish whether grommet insertion reduces the frequency of episodes of recurrent acute otitis media and the proportion of symptomatic children.
The Cochrane Ear, Nose and Throat Disorders Group (CENTDG) Trials Search Co-ordinator searched the CENTDG Trials Register; Central Register of Controlled Trials (CENTRAL 2014, Issue 10); PubMed; EMBASE; CINAHL; Web of Science; Clinicaltrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 6 November 2014.
Randomised controlled trials comparing grommet insertion versus control (antibiotics/other treatments/no treatment) for recurrent acute otitis media in children aged from 0 to 16 years.
Two authors independently selected studies. Three authors independently assessed study quality and extracted data. We synthesised data descriptively.
Two randomised controlled trials with a total of 148 participants are included in this review. The overall risk of bias in the studies is unclear.The first study randomised 95 children to grommets or control (antibiotic treatment of acute otitis media episodes). For the primary outcome, this study showed that grommet insertion leads to a mean reduction of 1.5 episodes of acute otitis media in the first six months after treatment. In six months of follow-up significantly more children in the grommet group had no episodes of acute otitis media (P value < 0.001). Complications of surgery included grommet blockage with acute otitis media requiring re-operation within six months in 3/54 children who underwent grommet insertion. Adverse effects were not documented in the control group. The following pre-defined secondary outcomes were not reported: change in symptom scores for otalgia or otorrhoea, alteration in the frequency of otalgia or otorrhoea, and number of days at nursery or school lost secondary to acute otitis media.The second study reported on 53 of 68 children who were randomised to grommet insertion or six months of once a day sulfamethoxazole and trimethoprim antibiotic prophylaxis. There was no significant difference in the primary outcome, number of episodes of acute otitis media, during the six-month follow-up between grommet insertion and antibiotic treatment groups (64.5% in the surgical group versus 45.4% in the antibiotic group had no recurrence, P value = 0.4). Two participants underwent grommet re-insertion to replace extruded tubes during the follow-up period. The only other adverse effect reported was the development of a skin rash in two patients in the medical group. Other pre-defined secondary outcome measures were not reported. The study has a high risk of bias and the results should be interpreted cautiously.
AUTHORS' CONCLUSIONS: Grommets significantly increase the number of acute otitis media-free children in the first six months after insertion compared to children who receive no treatment. Grommet insertion maybe of equivalent efficacy to once a day antibiotic prophylaxis. Further research is required to confirm the advantage of grommets over no treatment, investigate the effect beyond six months, compare grommet effectiveness against alternative active treatments and confirm the low risk of adverse effects compared to no treatment and all active treatments in recurrent acute otitis media. In the interim clinicians should consider the possible adverse effects of grommet insertion and alternative treatments before recommending surgery.
这是一篇Cochrane系统评价的更新版,该评价首次发表于《Cochrane图书馆》2008年第4期,此前于2011年进行过更新。急性化脓性中耳炎是儿童期最常见的传染病之一。本评价中复发性急性中耳炎的定义为:六个月内中耳裂发生三次或更多次急性感染,或一年内至少发作四次。该病的治疗策略包括尽可能评估和改变危险因素、每次新感染时重复使用抗生素疗程、抗生素预防以及插入通气管(鼓膜切开置管)。
确定插入通气管是否能降低复发性急性中耳炎的发作频率以及有症状儿童的比例。
Cochrane耳、鼻、喉疾病组(CENTDG)试验检索协调员检索了CENTDG试验注册库;对照试验中央注册库(CENTRAL 2014年第10期);PubMed;EMBASE;CINAHL;科学引文索引;Clinicaltrials.gov;国际临床试验注册平台(ICTRP)以及其他已发表和未发表试验的来源。检索日期为2014年11月6日。
比较0至16岁儿童复发性急性中耳炎插入通气管与对照(抗生素/其他治疗/不治疗)的随机对照试验。
两名作者独立选择研究。三名作者独立评估研究质量并提取数据。我们采用描述性方法综合数据。
本评价纳入了两项随机对照试验,共148名参与者。研究中的总体偏倚风险尚不清楚。第一项研究将95名儿童随机分为通气管组或对照组(对急性中耳炎发作进行抗生素治疗)。对于主要结局,该研究表明插入通气管在治疗后的前六个月使急性中耳炎发作次数平均减少1.5次。在六个月的随访中,通气管组明显更多的儿童没有急性中耳炎发作(P值<0.001)。手术并发症包括在插入通气管的54名儿童中有3名因急性中耳炎导致通气管堵塞而需要在六个月内再次手术。对照组未记录到不良反应。未报告以下预先定义的次要结局:耳痛或耳漏症状评分的变化、耳痛或耳漏频率的改变以及因急性中耳炎导致在托儿所或学校缺课的天数。第二项研究报告了68名随机分为插入通气管组或接受六个月每日一次磺胺甲恶唑和甲氧苄啶抗生素预防组中的53名儿童。在六个月的随访期间,插入通气管组和抗生素治疗组在主要结局急性中耳炎发作次数方面没有显著差异(手术组64.5%无复发,抗生素组45.4%无复发,P值=0.4)。在随访期间有两名参与者接受了通气管重新插入以更换脱出的通气管。报告的唯一其他不良反应是药物治疗组有两名患者出现皮疹。未报告其他预先定义的次要结局指标。该研究存在较高的偏倚风险,结果应谨慎解释。
与未接受治疗的儿童相比,插入通气管后在前六个月显著增加了无急性中耳炎儿童的数量。插入通气管可能与每日一次抗生素预防具有同等疗效。需要进一步研究以证实通气管相对于不治疗的优势,研究六个月后的效果,比较通气管与其他有效治疗方法的有效性,并证实与不治疗以及复发性急性中耳炎的所有有效治疗方法相比不良反应风险较低。在此期间,临床医生在推荐手术前应考虑插入通气管和替代治疗的可能不良反应。